These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 3170138)

  • 1. Delayed magnetic resonance hepatic imaging with gadolinium-DTPA.
    Nelson RC; Umpierrez ME; Chezmar JL; Bernardino ME
    Invest Radiol; 1988 Jul; 23(7):509-11. PubMed ID: 3170138
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of gadolinium 2,5-BPA-DO3A, a new macrocyclic hepatobiliary chelate, in normal liver and metastatic disease on high field magnetic resonance imaging.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1996 Jan; 31(1):11-6. PubMed ID: 8850360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic kinetics and magnetic resonance imaging of gadolinium-EOB-DTPA in dogs.
    Benness G; Khangure M; Morris I; Warwick A; Burrows P; Vogler H; Weinmann HJ
    Invest Radiol; 1996 Apr; 31(4):211-7. PubMed ID: 8721960
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gadolinium-DTPA enhanced dynamic MR imaging in the evaluation of cisplatinum nephrotoxicity.
    Frank JA; Choyke PL; Girton ME; Austin HA; Sievenpiper C; Inscoe SW; Black JL; Carvlin MJ; Dwyer AJ
    J Comput Assist Tomogr; 1989; 13(3):448-59. PubMed ID: 2723175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differentiation of hepatic hemangiomas from metastases by dynamic contrast-enhanced MR imaging.
    Hamm B; Fischer E; Taupitz M
    J Comput Assist Tomogr; 1990; 14(2):205-16. PubMed ID: 2312848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gd-DTPA adrenal gland enhancement at 1.5 T.
    Small WC; Bernardino ME
    Magn Reson Imaging; 1991; 9(3):309-12. PubMed ID: 1881248
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of gadolinium Cy2DOTA, a new hepatobiliary agent, and gadolinium HP-DO3A, an extracellular agent, in healthy liver and metastatic disease.
    Runge VM; Wells JW; Williams NM
    Invest Radiol; 1995 Feb; 30(2):123-30. PubMed ID: 7782188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gd-DTPA-cascade-polymer: potential blood pool contrast agent for MR imaging.
    Adam G; Neuerburg J; Spüntrup E; Mühler A; Scherer K; Günther RW
    J Magn Reson Imaging; 1994; 4(3):462-6. PubMed ID: 8061448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dynamic-contrast-enhanced magnetic resonance imaging of cirrhotic liver parenchyma: A comparison between gadolinium-diethylenetriamine pentaacetic acid and gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid.
    Lin CY; Chang WC; Chou CT; Chen RC
    J Chin Med Assoc; 2015 Nov; 78(11):666-72. PubMed ID: 26341453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic haemangioma: dynamic MRI using gadolinium-DTPA.
    Ohtomo K; Itai Y; Yoshikawa K; Kokubo T; Yashiro N; Iio M
    Eur J Radiol; 1987 Nov; 7(4):257-9. PubMed ID: 3691543
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dynamic sequential MR imaging of focal liver lesions: initial experience in 22 patients at 1.5 T.
    Schmiedl U; Kölbel G; Hess CF; Klose U; Kurtz B
    J Comput Assist Tomogr; 1990; 14(4):600-7. PubMed ID: 2164538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Contrast-enhancing properties of Gd-DTPA at 2.0 Tesla.
    Schmiedl U; Moseley MM; Ogan MD; Chew WM; Brasch RC
    Radiat Med; 1987; 5(1):1-5. PubMed ID: 3628851
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A comparative study between Gd-BOPTA, a biliary excretion contrast medium, and Gd-DTPA in the magnetic resonance imaging of the rat liver].
    Patrizio G; Pavone P; Cardone G; Pietroletti R; Passariello R; Tettamanti E; Musu C; Felder E
    Radiol Med; 1990 May; 79(5):458-62. PubMed ID: 2359853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Contrast-enhanced magnetic resonance cholangiography with Gd-BOPTA and Gd-EOB-DTPA in healthy subjects.
    Dahlström N; Persson A; Albiin N; Smedby O; Brismar TB
    Acta Radiol; 2007 May; 48(4):362-8. PubMed ID: 17453513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo fluorine-19 MR imaging: relaxation enhancement with Gd-DTPA.
    Lee H; Price RR; Holburn GE; Partain CL; Adams MD; Cacheris WP
    J Magn Reson Imaging; 1994; 4(4):609-13. PubMed ID: 7949689
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improved detection of acute myocardial infarction by magnetic resonance imaging using gadolinium-DTPA.
    van Dijkman PR; Doornbos J; de Roos A; van der Laarse A; Postema S; Matheijssen NA; Bruschke AV; van Voorthuisen AE; Cats VM; van der Wall EE
    Int J Card Imaging; 1989; 5(1):1-8. PubMed ID: 2614075
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of Gd-BOPTA with Gd-DTPA in MR imaging of rat liver.
    Pavone P; Patrizio G; Buoni C; Tettamanti E; Passariello R; Musu C; Tirone P; Felder E
    Radiology; 1990 Jul; 176(1):61-4. PubMed ID: 2353112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
    Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
    Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MR lymphography with a lymphotropic T1-type MR contrast agent: Gd-DTPA-PGM.
    Harika L; Weissleder R; Poss K; Zimmer C; Papisov MI; Brady TJ
    Magn Reson Med; 1995 Jan; 33(1):88-92. PubMed ID: 7891541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of MR imaging with liver-specific contrast agent: U.S. multicenter phase III study.
    Bluemke DA; Sahani D; Amendola M; Balzer T; Breuer J; Brown JJ; Casalino DD; Davis PL; Francis IR; Krinsky G; Lee FT; Lu D; Paulson EK; Schwartz LH; Siegelman ES; Small WC; Weber TM; Welber A; Shamsi K
    Radiology; 2005 Oct; 237(1):89-98. PubMed ID: 16126918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.